IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $1.43M invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$314K | |
| 2 | +$133K | |
| 3 | +$8.04K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$6.68K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.31K |
Top Sellers
| 1 | -$518K | |
| 2 | -$75.6K | |
| 3 | -$10K | |
| 4 |
Bank of New York Mellon
New York
|
-$5.55K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$5K |